June 18-20, 2017
GlaxoSmithKline, Tres Cantos, Madrid, Spain
The second edition of the meeting, organized by the Society for Chemical Industry’s Fine Chemicals Group, will focus on medicinal chemistry approaches to developing new medicines for diseases affecting global health. Keynote talks from international experts, alongside perspectives detailing case histories in drug discovery.
Ben Perry, NTD Drug Discovery Booster Project Manager, DNDi, will present on the NTD Drug Discovery Booster. Charles Mowbray, Head of Discovery, DNDi, will present on aminopyrazoles and NTDs.